Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Videos
Specialty Devices
Drug Delivery Devices
Return to: MDBR Home | Specialty Devices | Drug Delivery Devices | News
Search Refinements

Drug Delivery Devices News

View news from other Medical Devices sectors:
91-105 of 561 results
BD introduces simplified comprehensive IV management
By MDBR Staff Writer
BD (Becton, Dickinson and Company), a leading global medical technology company, introduced a simplified way for hospitals to manage intravenous (IV) medication to help improve safety and reduce waste.
Specialty Devices > Drug Delivery Devices > News
Unilife signs commercial supply agreement with MedImmune
By MDBR Staff Writer
Unilife, a US-based designer, developer and supplier of injectable drug delivery systems, announced the signing of the first supply agreement under its November 2013 Master Development and Supply Agreement (MDSA) with MedImmune, the global biologics research and development arm of AstraZeneca.
Specialty Devices > Drug Delivery Devices > News
Thinfilm and Ypsomed to develop new medical injection devices
By MDBR Staff Writer
Medical technology firm Ypsomed Group has collaborated with Thin Film Electronics to develop next generation medical injection devices.
Specialty Devices > Drug Delivery Devices > News
Medtronic begins REALITY study to assess IN.PACT Admiral DCB in patients with PAD
By MDBR Staff Writer
Irish medical technology firm Medtronic has started the REALITY study to assess the use of directional atherectomy and drug coated balloon in patients with peripheral arterial disease (PAD).
Specialty Devices > Drug Delivery Devices > News
Flowonix Medical and Cerebral Therapeutics announce exclusive agreement for drug delivery to brain
By MDBR Staff Writer
Flowonix Medical of New Jersey and Colorado-based Cerebral Therapeutics announced that they have entered into an exclusive agreement to develop a unique implanted drug delivery system which provides direct infusion of a therapeutic drug into targeted areas of the brain for treatment of neurological diseases.
Specialty Devices > Drug Delivery Devices > News
RenovoRx’s catheter obtains CE mark approval for targeted delivery of fluids
By MDBR Staff Writer
RenovoRx has received CE mark approval for its RenovoCath catheter, allowing the firm to provide EU physicians with a new tool for targeted delivery of fluids.
Specialty Devices > Drug Delivery Devices > News
ICU Medical and Medline to buy Excelsior Medical
By MDBR Staff Writer
ICU Medical has agreed to acquire Excelsior Medical from private equity firm RoundTable Healthcare Partners, for around $59.5m.
Specialty Devices > Drug Delivery Devices > News
QT Vascular announces interim clinical trial results of Chocolate Touch
By MDBR Staff Writer
QT Vascular, a global company engaged in the design, assembly and distribution of advanced therapeutic solutions for the minimally invasive treatment of vascular disease, announced the release of the interim results from ENDURE, the first study of its unique peripheral drug-coated balloon, Chocolate Touch.
Specialty Devices > Drug Delivery Devices > News
FDA approves Boston Scientific’s Synergy BP-DES system
By MDBR Staff Writer
Medical equipment manufacturer Boston Scientific has obtained approval from the US Food and Drug Administration (FDA) for its Synergy bioabsorbable polymer drug-eluting stent system (BP-DES) to treat coronary artery disease (CAD).
Specialty Devices > Drug Delivery Devices > News
STENTYS receives CE mark for self-apposing stent in lower limb artery disease
By MDBR Staff Writer
STENTYS, a medical technology company commercializing the world's first and only self-apposing coronary stent, announced that the company’s drug-eluting stent received CE mark for treatment of below-the-knee (BTK) arteries, making firm’s product the first self-expanding and drug-eluting stent with regulatory approval in Europe for this indication.
Specialty Devices > Drug Delivery Devices > News
Surefire Medical introduces new Precision infusion system
By MDBR Staff Writer
US-based Surefire Medical has introduced a new Precision targeted delivery infusion system for direct-to-tumor embolization procedures.
Specialty Devices > Drug Delivery Devices > News
Bayer’s Betaconnect obtains FDA approval to treat RRMS
By MDBR Staff Writer
Bayer HealthCare has received approval from the US Food and Drug Administration (FDA) for its Betaconnect, an electronic autoinjector developed to treat relapsing-remitting multiple sclerosis (RRMS).
Specialty Devices > Drug Delivery Devices > News
Enable Injections completes human pilot trial of wearable injector
By MDBR Staff Writer
US-based Enable Injections has completed the first-in-human pilot trial of the wearable injector. Dose delivery, injection pain and ease of use in subcutaneous self-delivery were assessed during the trial.
Specialty Devices > Drug Delivery Devices > News
QT Vascular receives CE mark approval for new peripheral drug-coated balloon
By MDBR Staff Writer
Singapore-based QT Vascular has received CE mark approval for its peripheral drug-coated balloon, Chocolate Touch.
Specialty Devices > Drug Delivery Devices > News
UK’s Innomech designs new automated test system for Owen Mumford’s auto-injectors
By MDBR Staff Writer
UK-based GB Innomech has developed a new fully automated test system, in a bid to help medical device manufacturer Owen Mumford to carry out effective batch testing as a final verification of quality for one of its auto-injector products.
Specialty Devices > Drug Delivery Devices > News
91-105 of 561 results